MLchartDataset catalogue

Kaletra

Term · Oncology and biomedicine · MLC-T-ONC-004605

A combination of the drugs ritonavir and lopinavir. It is used to treat infection with HIV (the virus that causes AIDS). It is also being studied in the treatment of some types of cancer. Kaletra blocks the ability of HIV to make copies of itself and may help other anticancer drugs work better or may block the growth of cancer cells. Ritonavir blocks the breakdown of lopinavir. Kaletra is a type of anti-HIV agent and a type of protease inhibitor. Also called lopinavir/ritonavir.

Table 1. Record
IdentifierMLC-T-ONC-004605
FieldOncology and biomedicine
Synonymslopinavir/ritonavir
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-004605",
  "term": "Kaletra",
  "field": "Oncology and biomedicine",
  "definition": "A combination of the drugs ritonavir and lopinavir. It is used to treat infection with HIV (the virus that causes AIDS). It is also being studied in the treatment of some types of cancer. Kaletra blocks the ability of HIV to make copies of itself and may help other anticancer drugs work better or may block the growth of cancer cells. Ritonavir blocks the breakdown of lopinavir. Kaletra is a type of anti-HIV agent and a type of protease inhibitor. Also called lopinavir/ritonavir.",
  "synonyms": [
    "lopinavir/ritonavir"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/kaletra/"
}

Record 9,721 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.